Have a personal or library account? Click to login
A rare case of medullary carcinoma of colon: Clinical implications and role of adjuvant therapy Cover

A rare case of medullary carcinoma of colon: Clinical implications and role of adjuvant therapy

Open Access
|Jul 2025

Abstract

Medullary carcinoma (MC) of the colon is one of the rarest types of colon adenocarcinoma with distinct phenotype and clinical outcomes. Annual incidence is noted to be around five to eight out of 10,000 cases of colon cancer, which is partly can be attributed to lack of understanding of these tumors for many years that has resulted in incorrect diagnosis. Comprehensive pathological examination is important along with immunohistochemical staining for accurate diagnosis of MC of the colon. It is usually diagnosed at stage 2 or 3, where surgery is the mainstay of treatment. Given the rarity of the tumor, there are no specific guidelines to direct adjuvant treatments. Most of the recommendations are inherited from colon adenocarcinoma guidelines. Here, we report a case report of elderly gentleman with early-stage medullary carcinoma of the colon and its prognosis, pathological findings, and treatment implications.

DOI: https://doi.org/10.2478/fco-2024-0005 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Submitted on: Nov 29, 2024
Accepted on: Jan 26, 2025
Published on: Jul 11, 2025
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2025 Lakshmi Manogna Chintalacheruvu, Vamsi Krishna Chilluru, Narendra Babu Gutta, Heather Barrett, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

AHEAD OF PRINT